Latest Regulatory Licensing News

NeuRizer Ltd advanced its urea project with Reliance Industries payments and environmental submissions, despite ongoing ASX trading suspension and overdue financial reports.

Xenitra Limited has acquired Hong Kong Fukang Trading Co., including key pharmaceutical licenses and ecommerce assets, to fully operationalise its OTC medicine business in Hong Kong and China.

Bioxyne Limited has reported a record $17.2 million in quarterly revenue, driven by strong growth in its cannabis and psychedelics segments, alongside strategic international expansions including a Frankfurt dual listing and new manufacturing agreements.

Mandrake Resources has signed a term sheet with DISA Technologies to explore recovering uranium and critical minerals from abandoned mine waste in Utah, leveraging a unique US regulatory license and strong government backing.

Ainsworth Game Technology’s board unanimously backs Novomatic’s $1.00 per share takeover offer, while a competing proportional bid at $1.30 per share emerges from a key shareholder.

Ainsworth Game Technology has received a proportional takeover offer at a 28.7% premium from Kjerulf Ainsworth, while its board continues to recommend the full takeover offer from Novomatic.

Cryosite Limited has inked a deal to acquire a strategic freehold warehouse in Auburn, NSW, doubling its storage capacity and positioning itself for significant growth in clinical trial logistics.

BetMakers Technology Group delivered a standout Q4 FY25 with record adjusted EBITDA and improved margins, while announcing a strategic acquisition to deepen its US market presence.

BetMakers Technology Group reports solid Q3 FY25 financial gains alongside a strategic binding agreement to acquire Nevada’s LVDC, expanding its global racing technology footprint.

Silex Systems reports steady progress on its TRL-6 uranium enrichment demonstration, targeting completion by end-2025, while securing initial US government funding to support commercialisation efforts.